Backes F - Search Results

1

Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients.

Hampel H, Pearlman R, de la Chapelle A, Pritchard CC, Zhao W, Jones D, Yilmaz A, Chen W, Frankel WL, Suarez AA, Cosgrove C, Backes F, Copeland L, Fowler J, O'Malley D, Salani R, McElroy JP, Stanich PP, Goodfellow P, Cohn DE. Hampel H, et al. Among authors: backes f. Gynecol Oncol. 2021 Jan;160(1):161-168. doi: 10.1016/j.ygyno.2020.10.012. Epub 2020 Oct 21. Gynecol Oncol. 2021. PMID: 33393477 Free PMC article.

2

Robotic trocar site small bowel evisceration after gynecologic cancer surgery.

Seamon LG, Backes F, Resnick K, Cohn DE. Seamon LG, et al. Among authors: backes f. Obstet Gynecol. 2008 Aug;112(2 Pt 2):462-4. doi: 10.1097/AOG.0b013e3181719ba8. Obstet Gynecol. 2008. PMID: 18669765

3

Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer.

Richardson DL, Backes FJ, Seamon LG, Zanagnolo V, O'Malley DM, Cohn DE, Fowler JM, Copeland LJ. Richardson DL, et al. Gynecol Oncol. 2008 Dec;111(3):461-6. doi: 10.1016/j.ygyno.2008.08.011. Epub 2008 Sep 30. Gynecol Oncol. 2008. PMID: 18829088

4

Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer.

Backes FJ, Leon ME, Ivanov I, Suarez A, Frankel WL, Hampel H, Fowler JM, Copeland LJ, O'Malley DM, Cohn DE. Backes FJ, et al. Gynecol Oncol. 2009 Sep;114(3):486-90. doi: 10.1016/j.ygyno.2009.05.026. Epub 2009 Jun 10. Gynecol Oncol. 2009. PMID: 19515405

5

Are prediction models for Lynch syndrome valid for probands with endometrial cancer?

Backes FJ, Hampel H, Backes KA, Vaccarello L, Lewandowski G, Bell JA, Reid GC, Copeland LJ, Fowler JM, Cohn DE. Backes FJ, et al. Fam Cancer. 2009;8(4):483-7. doi: 10.1007/s10689-009-9273-5. Epub 2009 Jul 30. Fam Cancer. 2009. PMID: 19642020

6

Lynch syndrome screening strategies among newly diagnosed endometrial cancer patients.

Resnick K, Straughn JM Jr, Backes F, Hampel H, Matthews KS, Cohn DE. Resnick K, et al. Among authors: backes f. Obstet Gynecol. 2009 Sep;114(3):530-536. doi: 10.1097/AOG.0b013e3181b11ecc. Obstet Gynecol. 2009. PMID: 19701031

7

Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?

Richardson DL, Backes FJ, Hurt JD, Seamon LG, Copeland LJ, Fowler JM, Cohn DE, O'Malley DM. Richardson DL, et al. Among authors: backes fj. Gynecol Oncol. 2010 Jul;118(1):47-51. doi: 10.1016/j.ygyno.2010.01.011. Epub 2010 Apr 10. Gynecol Oncol. 2010. PMID: 20382413

8

Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer.

O'Malley DM, Richardson DL, Rheaume PS, Salani R, Eisenhauer EL, McCann GA, Fowler JM, Copeland LJ, Cohn DE, Backes FJ. O'Malley DM, et al. Gynecol Oncol. 2011 May 1;121(2):269-72. doi: 10.1016/j.ygyno.2011.01.009. Epub 2011 Feb 18. Gynecol Oncol. 2011. PMID: 21315428

9

Lynch syndrome.

Backes FJ, Cohn DE. Backes FJ, et al. Clin Obstet Gynecol. 2011 Jun;54(2):199-214. doi: 10.1097/GRF.0b013e3182185a41. Clin Obstet Gynecol. 2011. PMID: 21508689 Review.

10

Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.

Salani R, Backes FJ, Fung MF, Holschneider CH, Parker LP, Bristow RE, Goff BA. Salani R, et al. Am J Obstet Gynecol. 2011 Jun;204(6):466-78. doi: 10.1016/j.ajog.2011.03.008. Am J Obstet Gynecol. 2011. PMID: 21752752 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page